R A Rosenheck
Overview
Explore the profile of R A Rosenheck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
2306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sayuk G, Kanuri N, Gyawali C, Gott B, Nix B, Rosenheck R
Aliment Pharmacol Ther
. 2018 Jan;
47(6):784-791.
PMID: 29327358
Background: While opioid prescriptions have increased alarmingly in the United States (US), their use for unexplained chronic gastrointestinal (GI) pain (eg, irritable bowel syndrome) carries an especially high risk for...
2.
Hoblyn J, Rosenheck R, Leatherman S, Weil L, Lew R
Psychiatr Q
. 2012 Nov;
84(2):209-18.
PMID: 23143523
Predictive characteristics of subjects agreeing to be randomized into clinical trials for the treatment of schizophrenia and schizoaffective disorder have been little studied. In this study, we used data from...
3.
Miller E, Rosenheck R, Schneider L
Curr Alzheimer Res
. 2009 Sep;
7(4):348-57.
PMID: 19715552
Objectives: To examine the relationship between multiple measures of health care costs and health utilities, quality of life, and other factors in Alzheimer's Disease (AD). Research Design: Data were obtained...
4.
Rosenheck R
Br J Psychiatry
. 2007 Sep;
191:238-45.
PMID: 17766765
Background: Second-generation antipsychotics may have few advantages over older, cheaper drugs, except for possibly reduced risk of tardive dyskinesia. Aims: To evaluate the cost-effectiveness of second-generation antipsychotics with regard to...
5.
Rosenheck R, Leslie D, Busch S, Rofman E, Sernyak M
Schizophr Bull
. 2007 Jul;
34(2):375-80.
PMID: 17634413
In this commentary, we review recent research suggesting that (a) second-generation antipsychotics (SGAs) may be no more effective than first-generation antipsychotics (FGAs), (b) the reduced risk of EPS and tardive...
6.
Harpaz-Rotem I, Rosenheck R
Child Care Health Dev
. 2006 Jan;
32(2):225-37.
PMID: 16441857
Objective: Although several studies have found that the most effective treatment for both youths and adults diagnosed with mood disorders is the combination of psychotherapy and medications, psychiatrists have been...
7.
Yonkers K, Pearlstein T, Rosenheck R
Arch Womens Ment Health
. 2003 Nov;
6(4):287-92.
PMID: 14628181
Introduction: As with a number of emotional disorders, premenstrual complaints lie on a continuum dictated by severity, number and type of symptoms experienced. Women with premenstrual dysphoric disorder (PMDD) generally...
8.
Nock M, Kaufman J, Rosenheck R
J Trauma Stress
. 2002 Jan;
14(4):835-41.
PMID: 11776428
This study examined several proposed predictors of severe wartime violence in a randomly selected, nationally representative sample of 1,125 Vietnam veterans. Participation in severe acts of violence during wartime was...
9.
Kessler R, Berglund P, Bruce M, Koch J, Laska E, Leaf P, et al.
Health Serv Res
. 2002 Jan;
36(6 Pt 1):987-1007.
PMID: 11775672
Objective: To identify the number of people in the United States with untreated serious mental illness (SMI) and the reasons for their lack of treatment. Data Source/study Design: The National...
10.
Rosenheck R, Dennis D
Arch Gen Psychiatry
. 2001 Dec;
58(11):1073-80.
PMID: 11695955
Background: The assertive community treatment (ACT) model for people with severe mental illness was originally designed to be provided continuously without termination. This study evaluated postdischarge changes in health status...